PE firm bought clinical trial services company in 2011 from Express Scripts
Parthenon concluded Eliza auction on Monday
Parthenon Capital Partners is inching toward the sale of yet another portfolio company, three people familiar with the process told Buyouts. The growth-oriented private equity firm is approaching the conclusion of what was said to be a sponsor-driven sales process for ...
This content is available for Buyouts subscribers only. Request a free trial to get access for a limited period